Entities / Company
Avidity.
American biotech company
- Reports this week
- 2
- Active events
- 1
- Connections
- 25
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
-
Novartis acquired Regulus Therapeutics in April, while also reportedly weighing a potential deal with Avidity Biosciences.Well supported10 reports1 development inside
-
Avidity Biosciences, a San Diego-based company, announced a partnership with Eli Lilly and is also facing acquisition interest from Novartis.Well supported7 reports1 development inside
One to three months ago
Gone quiet
No new reports in 90+ days-
Avidity listed its stock on the Nasdaq stock exchange on June 17, 2026.Some support1 report
-
Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.Some support1 report1 development inside
-
Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.Some support1 report
-
Avidity is headquartered in San Diego, CA.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Avidity this week
News at the entities that move Avidity most-
Novartis StructuralGSK and Novartis are identified as major pharmaceutical companies.Moves Avidity
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Avidity
-
Nasdaq OperationalApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Avidity
-
Cantor Fitzgerald Mentioned togetherAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves Avidity
-
Leerink partners Mentioned togetherAnalyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Moves Avidity
-
San Diego Shared contextLegal challenges are underway regarding San Diego's city policy on street vending, with an advocate speaking on behalf of Gaslamp Quarter businesses.Moves Avidity
Connections
The 7 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Structural
Novartis acquired Avidity Biosciences in a $12 billion buyout and continues to integrate its technology into its drug development pipeline.
-
Steve Hughes Structural
Steve Hughes holds the position of chief medical officer at Avidity.
-
FDA Structural
Avidity's drug development and market access are structurally dependent on regulatory approval and designation from the FDA.
-
Nasdaq Operational
Avidity is listed on the Nasdaq stock exchange.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald initiated market coverage of Avidity Biosciences as of August 2026.
-
Leerink partners Mentioned together
Leerink Partners initiated financial coverage on Avidity Biosciences.
-
San Diego Shared context
Avidity is headquartered and operates within San Diego, CA.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
1 eventJune 2026
6 events- Novartis acquired Regulus Therapeutics in April, while also reportedly weighing a potential deal with Avidity Biosciences.
- Avidity Biosciences, a San Diego-based company, announced a partnership with Eli Lilly and is also facing acquisition interest from Novartis.
- Avidity listed its stock on the Nasdaq stock exchange on June 17, 2026.
- Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.
- Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.
- Avidity is headquartered in San Diego, CA.